Loading…

Characterization of Plasmodium Atg3-Atg8 Interaction Inhibitors Identifies Novel Alternative Mechanisms of Action in Toxoplasma gondii

Protozoan parasites, including the apicomplexan pathogens (which causes malaria) and (which causes toxoplasmosis), infect millions of people worldwide and represent major human disease burdens. Despite their prevalence, therapeutic strategies to treat infections caused by these parasites remain limi...

Full description

Saved in:
Bibliographic Details
Published in:Antimicrobial agents and chemotherapy 2018-02, Vol.62 (2)
Main Authors: Varberg, Joseph M, LaFavers, Kaice A, Arrizabalaga, Gustavo, Sullivan, Jr, William J
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-a484t-2d555e42e603e102ed003b9de708ed250dd0d236975d4fc34edeb9ccece4eaa63
cites cdi_FETCH-LOGICAL-a484t-2d555e42e603e102ed003b9de708ed250dd0d236975d4fc34edeb9ccece4eaa63
container_end_page
container_issue 2
container_start_page
container_title Antimicrobial agents and chemotherapy
container_volume 62
creator Varberg, Joseph M
LaFavers, Kaice A
Arrizabalaga, Gustavo
Sullivan, Jr, William J
description Protozoan parasites, including the apicomplexan pathogens (which causes malaria) and (which causes toxoplasmosis), infect millions of people worldwide and represent major human disease burdens. Despite their prevalence, therapeutic strategies to treat infections caused by these parasites remain limited and are threatened by the emergence of drug resistance, highlighting the need for the identification of novel drug targets. Recently, homologues of the core autophagy proteins, including Atg8 and Atg3, were identified in many protozoan parasites. Importantly, components of the Atg8 conjugation system that facilitate the lipidation of Atg8 are required for both canonical and parasite-specific functions and are essential for parasite viability. Structural characterization of the Atg3-Atg8 (PfAtg3-Atg8) interaction has led to the identification of compounds that block this interaction. Additionally, many of these compounds inhibit growth , demonstrating the viability of this pathway as a drug target. Given the essential role of the Atg8 lipidation pathway in , we sought to determine whether three PfAtg3-Atg8 interaction inhibitors identified in the Medicines for Malaria Venture Malaria Box exerted a similar inhibitory effect in While all three inhibitors blocked replication at submicromolar concentrations, they did not inhibit Atg8 (TgAtg8) lipidation. Rather, high concentrations of two of these compounds induced TgAtg8 lipidation and fragmentation of the parasite mitochondrion, similar to the effects seen following starvation and monensin-induced autophagy. Additionally, we report that one of the PfAtg3-Atg8 interaction inhibitors induces egress and provide evidence that this is mediated by an increase in intracellular calcium in response to drug treatment.
doi_str_mv 10.1128/AAC.01489-17
format article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5786771</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>29158278</sourcerecordid><originalsourceid>FETCH-LOGICAL-a484t-2d555e42e603e102ed003b9de708ed250dd0d236975d4fc34edeb9ccece4eaa63</originalsourceid><addsrcrecordid>eNp1kctOAyEUhonRaL3sXBu2Jo4CAzPMxmTSeGlSLwtdEzqcaTEz0AzTRn0An1tqtdGFGwjhO9858CN0TMk5pUxelOXwnFAui4TmW2hASSGTTBTZNhoQkmUJl4Tvof0QXkg8i4Lsoj1WUCFZLgfoYzjTna566Oy77q132Nf4sdGh9cYuWlz20zSJi8QjF6FIrpiRm9mJ7X0X8MiA621tIeB7v4QGl03kXHQtAd9BNdPOhjastOW62Dr85F_9fNVE46l3xtpDtFPrJsDR936Anq-vnoa3yfjhZjQsx4nmkvcJM0II4AwykgIlDAwh6aQwkBMJhgliDDEszYpcGF5XKQcDk6KqoAIOWmfpAbpce-eLSQumirN3ulHzzra6e1NeW_X3xtmZmvqlErnM8pxGwdlaUHU-hA7qTS0lapWHinmorzwUzSN-usbjW5l68Yv4M034jz35PdtG_BNW-gmZYZce</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Characterization of Plasmodium Atg3-Atg8 Interaction Inhibitors Identifies Novel Alternative Mechanisms of Action in Toxoplasma gondii</title><source>American Society for Microbiology</source><source>Open Access: PubMed Central</source><creator>Varberg, Joseph M ; LaFavers, Kaice A ; Arrizabalaga, Gustavo ; Sullivan, Jr, William J</creator><creatorcontrib>Varberg, Joseph M ; LaFavers, Kaice A ; Arrizabalaga, Gustavo ; Sullivan, Jr, William J</creatorcontrib><description>Protozoan parasites, including the apicomplexan pathogens (which causes malaria) and (which causes toxoplasmosis), infect millions of people worldwide and represent major human disease burdens. Despite their prevalence, therapeutic strategies to treat infections caused by these parasites remain limited and are threatened by the emergence of drug resistance, highlighting the need for the identification of novel drug targets. Recently, homologues of the core autophagy proteins, including Atg8 and Atg3, were identified in many protozoan parasites. Importantly, components of the Atg8 conjugation system that facilitate the lipidation of Atg8 are required for both canonical and parasite-specific functions and are essential for parasite viability. Structural characterization of the Atg3-Atg8 (PfAtg3-Atg8) interaction has led to the identification of compounds that block this interaction. Additionally, many of these compounds inhibit growth , demonstrating the viability of this pathway as a drug target. Given the essential role of the Atg8 lipidation pathway in , we sought to determine whether three PfAtg3-Atg8 interaction inhibitors identified in the Medicines for Malaria Venture Malaria Box exerted a similar inhibitory effect in While all three inhibitors blocked replication at submicromolar concentrations, they did not inhibit Atg8 (TgAtg8) lipidation. Rather, high concentrations of two of these compounds induced TgAtg8 lipidation and fragmentation of the parasite mitochondrion, similar to the effects seen following starvation and monensin-induced autophagy. Additionally, we report that one of the PfAtg3-Atg8 interaction inhibitors induces egress and provide evidence that this is mediated by an increase in intracellular calcium in response to drug treatment.</description><identifier>ISSN: 0066-4804</identifier><identifier>EISSN: 1098-6596</identifier><identifier>DOI: 10.1128/AAC.01489-17</identifier><identifier>PMID: 29158278</identifier><language>eng</language><publisher>United States: American Society for Microbiology</publisher><subject>Antiprotozoal Agents ; Autophagy-Related Proteins ; Experimental Therapeutics ; Plasmodium falciparum ; Protein Isoforms ; Protozoan Proteins ; Small Molecule Libraries ; Toxoplasma</subject><ispartof>Antimicrobial agents and chemotherapy, 2018-02, Vol.62 (2)</ispartof><rights>Copyright © 2018 American Society for Microbiology.</rights><rights>Copyright © 2018 American Society for Microbiology. 2018 American Society for Microbiology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a484t-2d555e42e603e102ed003b9de708ed250dd0d236975d4fc34edeb9ccece4eaa63</citedby><cites>FETCH-LOGICAL-a484t-2d555e42e603e102ed003b9de708ed250dd0d236975d4fc34edeb9ccece4eaa63</cites><orcidid>0000-0003-1823-8642</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.asm.org/doi/pdf/10.1128/AAC.01489-17$$EPDF$$P50$$Gasm2$$H</linktopdf><linktohtml>$$Uhttps://journals.asm.org/doi/full/10.1128/AAC.01489-17$$EHTML$$P50$$Gasm2$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,3188,27924,27925,52751,52752,52753,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29158278$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Varberg, Joseph M</creatorcontrib><creatorcontrib>LaFavers, Kaice A</creatorcontrib><creatorcontrib>Arrizabalaga, Gustavo</creatorcontrib><creatorcontrib>Sullivan, Jr, William J</creatorcontrib><title>Characterization of Plasmodium Atg3-Atg8 Interaction Inhibitors Identifies Novel Alternative Mechanisms of Action in Toxoplasma gondii</title><title>Antimicrobial agents and chemotherapy</title><addtitle>Antimicrob Agents Chemother</addtitle><addtitle>Antimicrob Agents Chemother</addtitle><description>Protozoan parasites, including the apicomplexan pathogens (which causes malaria) and (which causes toxoplasmosis), infect millions of people worldwide and represent major human disease burdens. Despite their prevalence, therapeutic strategies to treat infections caused by these parasites remain limited and are threatened by the emergence of drug resistance, highlighting the need for the identification of novel drug targets. Recently, homologues of the core autophagy proteins, including Atg8 and Atg3, were identified in many protozoan parasites. Importantly, components of the Atg8 conjugation system that facilitate the lipidation of Atg8 are required for both canonical and parasite-specific functions and are essential for parasite viability. Structural characterization of the Atg3-Atg8 (PfAtg3-Atg8) interaction has led to the identification of compounds that block this interaction. Additionally, many of these compounds inhibit growth , demonstrating the viability of this pathway as a drug target. Given the essential role of the Atg8 lipidation pathway in , we sought to determine whether three PfAtg3-Atg8 interaction inhibitors identified in the Medicines for Malaria Venture Malaria Box exerted a similar inhibitory effect in While all three inhibitors blocked replication at submicromolar concentrations, they did not inhibit Atg8 (TgAtg8) lipidation. Rather, high concentrations of two of these compounds induced TgAtg8 lipidation and fragmentation of the parasite mitochondrion, similar to the effects seen following starvation and monensin-induced autophagy. Additionally, we report that one of the PfAtg3-Atg8 interaction inhibitors induces egress and provide evidence that this is mediated by an increase in intracellular calcium in response to drug treatment.</description><subject>Antiprotozoal Agents</subject><subject>Autophagy-Related Proteins</subject><subject>Experimental Therapeutics</subject><subject>Plasmodium falciparum</subject><subject>Protein Isoforms</subject><subject>Protozoan Proteins</subject><subject>Small Molecule Libraries</subject><subject>Toxoplasma</subject><issn>0066-4804</issn><issn>1098-6596</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp1kctOAyEUhonRaL3sXBu2Jo4CAzPMxmTSeGlSLwtdEzqcaTEz0AzTRn0An1tqtdGFGwjhO9858CN0TMk5pUxelOXwnFAui4TmW2hASSGTTBTZNhoQkmUJl4Tvof0QXkg8i4Lsoj1WUCFZLgfoYzjTna566Oy77q132Nf4sdGh9cYuWlz20zSJi8QjF6FIrpiRm9mJ7X0X8MiA621tIeB7v4QGl03kXHQtAd9BNdPOhjastOW62Dr85F_9fNVE46l3xtpDtFPrJsDR936Anq-vnoa3yfjhZjQsx4nmkvcJM0II4AwykgIlDAwh6aQwkBMJhgliDDEszYpcGF5XKQcDk6KqoAIOWmfpAbpce-eLSQumirN3ulHzzra6e1NeW_X3xtmZmvqlErnM8pxGwdlaUHU-hA7qTS0lapWHinmorzwUzSN-usbjW5l68Yv4M034jz35PdtG_BNW-gmZYZce</recordid><startdate>20180201</startdate><enddate>20180201</enddate><creator>Varberg, Joseph M</creator><creator>LaFavers, Kaice A</creator><creator>Arrizabalaga, Gustavo</creator><creator>Sullivan, Jr, William J</creator><general>American Society for Microbiology</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-1823-8642</orcidid></search><sort><creationdate>20180201</creationdate><title>Characterization of Plasmodium Atg3-Atg8 Interaction Inhibitors Identifies Novel Alternative Mechanisms of Action in Toxoplasma gondii</title><author>Varberg, Joseph M ; LaFavers, Kaice A ; Arrizabalaga, Gustavo ; Sullivan, Jr, William J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a484t-2d555e42e603e102ed003b9de708ed250dd0d236975d4fc34edeb9ccece4eaa63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Antiprotozoal Agents</topic><topic>Autophagy-Related Proteins</topic><topic>Experimental Therapeutics</topic><topic>Plasmodium falciparum</topic><topic>Protein Isoforms</topic><topic>Protozoan Proteins</topic><topic>Small Molecule Libraries</topic><topic>Toxoplasma</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Varberg, Joseph M</creatorcontrib><creatorcontrib>LaFavers, Kaice A</creatorcontrib><creatorcontrib>Arrizabalaga, Gustavo</creatorcontrib><creatorcontrib>Sullivan, Jr, William J</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Antimicrobial agents and chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Varberg, Joseph M</au><au>LaFavers, Kaice A</au><au>Arrizabalaga, Gustavo</au><au>Sullivan, Jr, William J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Characterization of Plasmodium Atg3-Atg8 Interaction Inhibitors Identifies Novel Alternative Mechanisms of Action in Toxoplasma gondii</atitle><jtitle>Antimicrobial agents and chemotherapy</jtitle><stitle>Antimicrob Agents Chemother</stitle><addtitle>Antimicrob Agents Chemother</addtitle><date>2018-02-01</date><risdate>2018</risdate><volume>62</volume><issue>2</issue><issn>0066-4804</issn><eissn>1098-6596</eissn><abstract>Protozoan parasites, including the apicomplexan pathogens (which causes malaria) and (which causes toxoplasmosis), infect millions of people worldwide and represent major human disease burdens. Despite their prevalence, therapeutic strategies to treat infections caused by these parasites remain limited and are threatened by the emergence of drug resistance, highlighting the need for the identification of novel drug targets. Recently, homologues of the core autophagy proteins, including Atg8 and Atg3, were identified in many protozoan parasites. Importantly, components of the Atg8 conjugation system that facilitate the lipidation of Atg8 are required for both canonical and parasite-specific functions and are essential for parasite viability. Structural characterization of the Atg3-Atg8 (PfAtg3-Atg8) interaction has led to the identification of compounds that block this interaction. Additionally, many of these compounds inhibit growth , demonstrating the viability of this pathway as a drug target. Given the essential role of the Atg8 lipidation pathway in , we sought to determine whether three PfAtg3-Atg8 interaction inhibitors identified in the Medicines for Malaria Venture Malaria Box exerted a similar inhibitory effect in While all three inhibitors blocked replication at submicromolar concentrations, they did not inhibit Atg8 (TgAtg8) lipidation. Rather, high concentrations of two of these compounds induced TgAtg8 lipidation and fragmentation of the parasite mitochondrion, similar to the effects seen following starvation and monensin-induced autophagy. Additionally, we report that one of the PfAtg3-Atg8 interaction inhibitors induces egress and provide evidence that this is mediated by an increase in intracellular calcium in response to drug treatment.</abstract><cop>United States</cop><pub>American Society for Microbiology</pub><pmid>29158278</pmid><doi>10.1128/AAC.01489-17</doi><tpages>19</tpages><orcidid>https://orcid.org/0000-0003-1823-8642</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0066-4804
ispartof Antimicrobial agents and chemotherapy, 2018-02, Vol.62 (2)
issn 0066-4804
1098-6596
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5786771
source American Society for Microbiology; Open Access: PubMed Central
subjects Antiprotozoal Agents
Autophagy-Related Proteins
Experimental Therapeutics
Plasmodium falciparum
Protein Isoforms
Protozoan Proteins
Small Molecule Libraries
Toxoplasma
title Characterization of Plasmodium Atg3-Atg8 Interaction Inhibitors Identifies Novel Alternative Mechanisms of Action in Toxoplasma gondii
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T00%3A19%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Characterization%20of%20Plasmodium%20Atg3-Atg8%20Interaction%20Inhibitors%20Identifies%20Novel%20Alternative%20Mechanisms%20of%20Action%20in%20Toxoplasma%20gondii&rft.jtitle=Antimicrobial%20agents%20and%20chemotherapy&rft.au=Varberg,%20Joseph%20M&rft.date=2018-02-01&rft.volume=62&rft.issue=2&rft.issn=0066-4804&rft.eissn=1098-6596&rft_id=info:doi/10.1128/AAC.01489-17&rft_dat=%3Cpubmed_cross%3E29158278%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a484t-2d555e42e603e102ed003b9de708ed250dd0d236975d4fc34edeb9ccece4eaa63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/29158278&rfr_iscdi=true